{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:46:53Z","timestamp":1786121213001,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023392","name":"NIHR Barts Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jval.2026.06.016","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:02:03Z","timestamp":1784044923000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Preventive Treatment on Healthcare Use: A Modeling Study of Statin Treatment"],"prefix":"10.1016","author":[{"given":"Junwen","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runguo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borislava","family":"Mihaylova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.jval.2026.06.016_bib1","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","article-title":"The global burden of cardiovascular diseases and risk","volume":"80","author":"Vaduganathan","year":"2022","journal-title":"JACC"},{"key":"10.1016\/j.jval.2026.06.016_bib2","series-title":"BHF UK CVD factsheet","year":"2025"},{"issue":"9841","key":"10.1016\/j.jval.2026.06.016_bib4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jval.2026.06.016_bib5","article-title":"Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling study","volume":"40","author":"Mihaylova","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"21","key":"10.1016\/j.jval.2026.06.016_bib6","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1136\/heartjnl-2024-324052","article-title":"Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study","volume":"110","author":"Mihaylova","year":"2024","journal-title":"Heart"},{"issue":"9753","key":"10.1016\/j.jval.2026.06.016_bib7","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"issue":"9716","key":"10.1016\/j.jval.2026.06.016_bib8","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jval.2026.06.016_bib10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s11606-014-3089-1","article-title":"Why do people avoid medical care? A qualitative study using national data","volume":"30","author":"Taber","year":"2015","journal-title":"J Gen Intern Med"},{"issue":"5","key":"10.1016\/j.jval.2026.06.016_bib11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/eurheartj\/eht232","article-title":"Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study","volume":"35","author":"McConnachie","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jval.2026.06.016_bib12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/1472-6963-9-198","article-title":"The impact of statins on health services utilization and mortality in older adults discharged from hospital with ischemic heart disease: a cohort study","volume":"9","author":"Cooke","year":"2009","journal-title":"BMC Health Serv Res"},{"issue":"740","key":"10.1016\/j.jval.2026.06.016_bib13","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.3399\/BJGP.2023.0198","article-title":"Long-term cardiovascular risks and the impact of statin treatment on socioeconomic inequalities: a microsimulation model","volume":"74","author":"Wu","year":"2024","journal-title":"Br J Gen Pract"},{"issue":"3","key":"10.1016\/j.jval.2026.06.016_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLOS Med"},{"issue":"5","key":"10.1016\/j.jval.2026.06.016_bib15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40273-022-01219-6","article-title":"Prediction models for individual-level healthcare costs associated with cardiovascular events in the UK","volume":"41","author":"Zhou","year":"2023","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.1016\/j.jval.2026.06.016_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40273-023-01319-x","article-title":"Estimating costs associated with disease model states using generalized linear models: a tutorial","volume":"42","author":"Zhou","year":"2024","journal-title":"Pharmacoeconomics"},{"issue":"16","key":"10.1016\/j.jval.2026.06.016_bib17","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0002-9149(99)80744-9","article-title":"Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens","volume":"75","year":"1995","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.jval.2026.06.016_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/ije\/dyh372","article-title":"Cohort Profile: the Whitehall II study","volume":"34","author":"Marmot","year":"2005","journal-title":"Int J Epidemiol"},{"issue":"7404","key":"10.1016\/j.jval.2026.06.016_bib19","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/bmj.326.7404.1423","article-title":"Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"issue":"8A","key":"10.1016\/j.jval.2026.06.016_bib20","doi-asserted-by":"crossref","first-page":"52C","DOI":"10.1016\/j.amjcard.2005.12.010","article-title":"Statin safety: a systematic review","volume":"97","author":"Law","year":"2006","journal-title":"Am J Cardiol"},{"issue":"24","key":"10.1016\/j.jval.2026.06.016_bib21","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1001\/jama.2011.860","article-title":"Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis","volume":"305","author":"Preiss","year":"2011","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jval.2026.06.016_bib22","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/pds.5023","article-title":"The impact of statin discontinuation and restarting rates on the optimal time to initiate statins and on the number of cardiovascular events prevented","volume":"29","author":"Pate","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"662","key":"10.1016\/j.jval.2026.06.016_bib23","doi-asserted-by":"crossref","first-page":"e598","DOI":"10.3399\/bjgp17X692141","article-title":"Application of the 2014 NICE cholesterol guidelines in the English population: a cross-sectional analysis","volume":"67","author":"Ueda","year":"2017","journal-title":"Br J Gen Pract"},{"issue":"5","key":"10.1016\/j.jval.2026.06.016_bib24","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/heartjnl-2022-321452","article-title":"Population-wide cohort study of statin use for the secondary cardiovascular disease prevention in Scotland in 2009-2017","volume":"109","author":"Thalmann","year":"2023","journal-title":"Heart"},{"issue":"12","key":"10.1016\/j.jval.2026.06.016_bib25","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1345\/aph.1P281","article-title":"A pharmaceutical care program to improve adherence to statin therapy: a randomized controlled trial","volume":"44","author":"Eussen","year":"2010","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.jval.2026.06.016_bib26","article-title":"Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease","volume":"3","author":"Redfern","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.jval.2026.06.016_bib27","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.19429","article-title":"Effect of patient financial incentives on statin adherence and lipid control: a randomized clinical trial","volume":"3","author":"Barankay","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.jval.2026.06.016_bib28","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/clc.23555","article-title":"Communication approaches to enhance patient motivation and adherence in cardiovascular disease prevention","volume":"44","author":"Duffy","year":"2021","journal-title":"Clin Cardiol"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301526025362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301526025362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T03:27:23Z","timestamp":1786073243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301526025362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":26,"alternative-id":["S1098301526025362"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2026.06.016","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Preventive Treatment on Healthcare Use: A Modeling Study of Statin Treatment","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2026.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}